Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq Profiling of Response to Cisplatin and Gemcitabine Chemotherapy in Advanced Urothelial Carcinoma: An External Validation Cohort

ABSTRACT: This dataset includes RNA sequencing data from formalin-fixed paraffin-embedded (FFPE) tumor samples of advanced urothelial carcinoma patients treated with cisplatin and gemcitabine combination chemotherapy at Pusan National University Yangsan Hospital (PNUYH). RNA was extracted using the RNeasy FFPE kit (Qiagen) and sequenced on the Illumina platform using the SureSelectXT RNA Direct Reagent Kit (Agilent) for paired-end sequencing. Raw sequencing data underwent quality control and trimming using Trimmomatic-0.39-1, followed by sequence alignment using STAR 2.7.8a and expression quantification using RSEM 1.3.3. Treatment responses were evaluated according to RECIST v1.1 criteria. This dataset serves as an external validation cohort for a deep learning-based chemotherapy response prediction model in urothelial carcinoma.

ORGANISM(S): Homo sapiens

PROVIDER: GSE290327 | GEO | 2026/02/24

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Urothelial carcinoma chemotherapy response

| PRJNA1078523 | ENA

Examination of microRNA expression in pre- and post-treatment plasma samples of 3 patients

Project description:Drug resistance often tempers the clinical benefit of chemotherapy in human malignant tumors. The potential chemosensitization of low-dose decitabine has been evident both preclinically and in previous phase I trials. Emerging data showed that miRNAs play an important role as a prognostic factor for cancer survival. Given that the biopsy tumor tissue was often not available, especially for patients with relapsed or refractory cancer, plasma RNA provided a valuable source for biomarker development. In order to establish predictive biomarker signature for the clinical efficacy of the decitabine-primed chemotherapy, we evaluated the expression of plasma miRNAs via high throughput microRNA sequencing. We performed miRNA-seq on a training set of 2 partial response (PR) patients and 1 progressive disease (PD) patients, and revealed preliminary data that plasma miRNA expression signature may serve as putative predictive markers of the low-dose decitabine primed chemotherapy. The clinical responses were assessed in a blinded manner according to the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.

2016-12-15 | GSE91089 | GEO

Bladder Cancer Clinical Cohorts

Project description:<p>Cisplatin-based chemotherapy is the standard of care for patients with muscle invasive urothelial carcinoma. Pathologic downstaging to pT0/pTis after neoadjuvant cisplatin-based chemotherapy is associated with improved survival, and some patients with metastatic disease achieve complete responses to these therapies. However, the molecular determinants of cisplatin response are incompletely understood. We performed whole exome sequencing on tumor and germline DNA from patients with muscle invasive or metastatic urothelial carcinoma who received cisplatin-based chemotherapy to identify somatic mutations that occurred preferentially in cisplatin responders.</p>

| phs000771 | dbGaP

DNA copy number gain at 1q23.3 is associated with poor survival in metastatic bladder cancer [Agilent]

Project description:Metastatic urothelial carcinoma (UC) of the bladder is associated with multiple somatic copy number alterations (SCNAs). We evaluated SCNAs to identify predictors of poor survival in patients with metastatic UC treated with platinum chemotherapy.

2013-07-07 | GSE39281 | GEO

DNA copy number gain at 1q23.3 is associated with poor survival in metastatic bladder cancer [Affymetrix]

2013-07-07 | GSE39280 | GEO

Methylation array of upper urinary tract urothelial carcinoma

Project description:Genome-wide methylation analysis of upper urinary tract urothelial carcinoma using Infinium MethylationEPIC BeadChip Kit

| EGAD00010002096 | EGA

Differential neoadjuvant chemotherapy response in urothelial carcinoma molecular subtypes

Project description:Differential neoadjuvant chemotherapy response in urothelial carcinoma molecular subtypes

| PRJNA716648 | ENA

Methylation profiling of choroid plexus carcinoma cell lines

Project description:Genomic DNA was extracted from two choroid plexus carcinoma cell lines using the GeneJET genomic DNA (Thermo Fisher). DNA was quantified using the DENOVIX Fluorometer. The quality of the extracted DNA samples was assessed by the Illumina FFPE QC kit (Illumina). Bisulfite conversion of the DNA was performed using the EZ DNA methylation kit (Zymo). Bisulfite-converted DNA was hybridized to the Illumina Infinium Human Methylation EPIC array bead chip and scanned using the Illumina iScan microarray scanner (Illumina) according to the manufacturer protocol.

2024-01-01 | GSE236509 | GEO

Expression data of squamous cervical carcinoma after chemotherapy

Project description:The patients with locally advanced squamous cervical cancer (SCC) were examined in this study. All patients received neoadjuvant chemotherapy followed by radical hysterectomy. Tumor response against NAC was determined based on RECIST criterior. Gene-expression profiles of SCC were determined using Human Genome GeneChip arrays U133.

2015-06-23 | GSE70035 | GEO

Feasibility of global microRNA analysis from fine-needle biopsy FFPE material in patients with hepatocellular carcinoma treated with sorafenib

Project description:Tumor cells were microdissected from FFPE sections of hepatocellular carcinoma (HCC) samples. micro RNA expression were correlated to clinical outcome and sorafenib-therapy. miRNA was labeled with the Affymetrix FlashTag Biotin HSR RNA Labeling Kit

2014-07-29 | GSE56059 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data